ResMed (RMD) CEO Mick Farrell joins Morning Trade Live to discuss the company’s latest earnings beat. ResMed primarily focuses on sleep apnea and COPD. He talks about GLP-1 medications and consumer tech offering medical monitoring like the Apple (AAPL) Watch. He discusses the customer base for ResMed and its hardware vs software businesses.